2m 2m 2m 2m 2m 2m 2m
VOR BIOPHARMA (VOR)
NASDAQ
$19.03-$0.29 (-1.50%)
Price as of Nov 13, 2026 1:54 PM EST- $1.2BMarket Cap
- 98.15%1-Year Change
- BiotechnologyIndustry
VOR BIOPHARMA (VOR)
$19.03-$0.29 (-1.50%)
VOR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.32 | ||
Change | -$0.77 (-3.83%) | ||
Open | $19.61 | ||
High | $19.88 | ||
Low | $18.98 | ||
Previous Close | $20.09 | ||
Volume | 796,369 | ||
30-Day Average Volume | 735,660 | ||
1-Week Change | 3.54% | ||
1-Month Change | -2.42% | ||
1-Year Change | 98.15% | ||
3-Year Change | -45.11% | ||
5-Year Change | -94.56% | ||
Fundamentals | |||
Shares Outstanding | 61.4M | ||
Total Assets | $496.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$86.7M | ||
Free Cash Flow | -$32.8M | ||
EBIT | -$86.7M | ||
EBITDA | -$86.7M | ||
Net Working Capital | $454.2M | ||
EPS | -$1.45 | ||
Enterprise Value/EBITDA | -13 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -9 | ||
P/E | -13 | ||
PEG | 1 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 09/19/2025 | ||
Earnings & Revenue